THE WOODLANDS, Texas, Oct. 30 /PRNewswire/ -- Lexicon Genetics Incorporated (Nasdaq: LEXG) will announce its third quarter 2001 financial results before the market opens on November 6th.

The Company will sponsor a conference call on November 6th, which will be broadcast live over the Internet, beginning at 8:00 a.m. EST. Arthur T. Sands, M.D., Ph.D., President and Chief Executive Officer, and Julia P. Gregory, Executive Vice President and Chief Financial Officer, will review Lexicons operating highlights and financial results for the third quarter ended September 30, 2001 and will discuss forward looking information for the fourth quarter 2001.

The live webcast can be accessed by visiting Lexicons website at www.lexicon-genetics.com or www.streetevents.com . Following the webcast, an archived version of the call will be available on Lexicons website through November 9th. Investors may listen to the call by dialing 800/967-7140 (domestic), pass code: 735072; or 719/457-2629 (international), pass code: 735072. A replay of the call will be available until 6 p.m. EST on November 9th. The replay number for domestic callers is 888/203-1112 pass code 735072 and international callers should dial 719/457-0820 pass code 735072.

Note: Minimum requirements to listen to the broadcast are RealPlayer software and at least a 14.4Kbps connection to the Internet. RealPlayer software is a free download from www.real.com/products/player/index.html .

Lexicon Genetics Incorporated is a drug discovery company of the post-genome era, using gene knockout technology to define the functions of genes for the discovery of pharmaceutical products. Lexicon is using this technology to fuel drug discovery programs in cancer, cardiovascular disease, immune disorders, neurological disease, diabetes and obesity. Lexicon has established drug discovery alliances and functional genomics collaborations with leading pharmaceutical and biotechnology companies, research institutes and academic institutions throughout the world to commercialize its technology and further develop its discoveries. Additional information about the Company is available through Lexicons corporate website, www.lexicon-genetics.com .

This press release contains "forward-looking statements," including statements about Lexicons growth and future operating results, discovery and development of products, strategic alliances, and intellectual property, as well as other matters that are not historical facts or information. These forward-looking statements are based on managements current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicons ability to achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, that may cause Lexicons actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Business - Risk Factors" in Lexicons annual report on Form 10-K for the year ended December 31, 2000, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.